NanoBRET Saturation Analysis with a Novel HaloTag Ligand Reveals Butyrophilin Heteromeric Interactions Controlling γ9δ2 T Cell Activation
ACS Chemical Biology · 17.07.2026 · 21 (7) · 1665-1677
DOI: 10.1021/acschembio.6c00219 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 18.06.2026. Verfasst von Girija Pawge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, United States. Hauptthemen laut MEDLINE: Butyrophilins, Lymphocyte Activation, T-Lymphocytes, Antigens, CD. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health (NIH).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, United States.
- Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut 06269, United States.
ORCID-Profile: Girija Pawge, Andrew J Wiemer
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institutes of Health (NIH)
Zitieren
APA
Pawge, G., Bashir, S., Parikh, R., Hsiao, C. C., & Wiemer, A. J. (2026). NanoBRET Saturation Analysis with a Novel HaloTag Ligand Reveals Butyrophilin Heteromeric Interactions Controlling γ9δ2 T Cell Activation. ACS Chemical Biology, 21(7), 1665-1677. https://doi.org/10.1021/acschembio.6c00219
Vancouver
Pawge G, Bashir S, Parikh R, Hsiao CC, Wiemer AJ. NanoBRET Saturation Analysis with a Novel HaloTag Ligand Reveals Butyrophilin Heteromeric Interactions Controlling γ9δ2 T Cell Activation. ACS Chemical Biology. 2026;21(7):1665-1677. doi:10.1021/acschembio.6c00219
BibTeX
@article{Pawge2026,
author = {Pawge, Girija and Bashir, Sidra and Parikh, Ritika and Hsiao, Chia-Hung Christine and Wiemer, Andrew J},
title = {NanoBRET Saturation Analysis with a Novel HaloTag Ligand Reveals Butyrophilin Heteromeric Interactions Controlling γ9δ2 T Cell Activation},
journal = {ACS Chemical Biology},
year = {2026},
volume = {21},
number = {7},
pages = {1665--1677},
doi = {10.1021/acschembio.6c00219}
}
EUVIMED